Advertisement
Journal Home
Search for

24 Periodical Search Results

You searched for "extended" AND "duration" OR "time factors" AND "of" AND "action" within European Urology

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 24 results   Next 4>

Results Page:  [1]  2

display abstract citation download email a colleague
Display:

  1. Extended Duration of Efficacy of Vardenafil When Taken 8 Hours Before Intercourse: A Randomized, Double-Blind, Placebo-Controlled Study , 06 June 2006
    Hartmut Porst, Ira D. Sharlip, Dimitris Hatzichristou, Eusebio Rubio-Aurioles, Marc Gittelman, Britt-Nicole Stancil, Peter M. Smith, H. Jeffrey Wilkins, Peter Pommerville, for the Vardenafil Study Group
    European Urology
    November 2006 (Vol. 50, Issue 5, Pages 1086-1095)
    Abstract | Full Text | Full-Text PDF (1257 KB)

  1. Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications , 15 July 2007
    Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi, Gerald B. Brock
    European Urology
    October 2007 (Vol. 52, Issue 4, Pages 990-1005)
    Abstract | Full Text | Full-Text PDF (683 KB)

  1. Tolterodine Extended Release With or Without Tamsulosin in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms: Effects of Prostate Size , 18 June 2008
    Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan
    European Urology
    February 2009 (Vol. 55, Issue 2, Pages 472-481)
    Abstract | Full Text | Full-Text PDF (335 KB)

  1. Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review , 02 August 2006
    Giacomo Novara, Antonio Galfano, Vincenzo Ficarra, Walter Artibani
    European Urology
    October 2006 (Vol. 50, Issue 4, Pages 675-683)
    Abstract | Full Text | Full-Text PDF (146 KB)

  1. Amino-Terminal Pro-C-Type Natriuretic Peptide is Associated with the Presence, Severity, and Duration of Vasculogenic Erectile Dysfunction , 25 November 2008
    Charalambos Vlachopoulos, Nikolaos Ioakeimidis, Dimitrios Terentes-Printzios, Konstantinos Rokkas, Konstantinos Aznaouridis, Katerina Baou, Athanasios Bratsas, Charalambos Fassoulakis, Christodoulos Stefanadis
    European Urology
    September 2009 (Vol. 56, Issue 3, Pages 552-558)
    Abstract | Full Text | Full-Text PDF (370 KB)

  1. Botulinum Toxin as a New Therapy Option for Voiding Disorders: Current State of the Art
    Thomas Leippold, André Reitz, Brigitte Schurch
    European Urology
    August 2003 (Vol. 44, Issue 2, Pages 165-174)
    Abstract | Full Text | Full-Text PDF (223 KB)

  1. The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis , 24 March 2005
    Christopher Chapple, Vik Khullar, Zahava Gabriel, Julie Ann Dooley
    European Urology
    July 2005 (Vol. 48, Issue 1, Pages 5-26)
    Abstract | Full Text | Full-Text PDF (1335 KB)

  1. Differential Effects of the Antimuscarinic Agents Darifenacin and Oxybutynin ER on Memory in Older Subjects , 24 April 2006
    Gary Kay, Thomas Crook, Ludmyla Rekeda, Raul Lima, Ursula Ebinger, Miguel Arguinzoniz, Michael Steel
    European Urology
    August 2006 (Vol. 50, Issue 2, Pages 317-326)
    Abstract | Full Text | Full-Text PDF (306 KB)

  1. Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results after Five Injections in Patients with Neurogenic Detrusor Overactivity , 03 September 2007
    André Reitz, Pierre Denys, Christophe Fermanian, Brigitte Schurch, Eva Comperat, Emmanuel Chartier-Kastler
    European Urology
    December 2007 (Vol. 52, Issue 6, Pages 1729-1735)
    Abstract | Full Text | Full-Text PDF (429 KB)

  1. Dehydroepiandrosterone Treatment in the Aging Male – What Should the Urologist Know? , 18 July 2005
    F. Saad, C.E. Hoesl, M. Oettel, J.-D. Fauteck, A. Römmler
    European Urology
    November 2005 (Vol. 48, Issue 5, Pages 724-733)
    Abstract | Full Text | Full-Text PDF (428 KB)

  1. The Long-Term Outcome of Medical Therapy for BPH , 31 March 2007
    Stephan Madersbacher, Martin Marszalek, Jakob Lackner, Peter Berger, Georg Schatzl
    European Urology
    June 2007 (Vol. 51, Issue 6, Pages 1522-1533)
    Abstract | Full Text | Full-Text PDF (574 KB)

  1. The Current Status of Therapy for Symptomatic Late-Onset Hypogonadism with Transdermal Testosterone Gel , 21 October 2004
    T. Ebert, F. Jockenhövel, A. Morales, R. Shabsigh
    European Urology
    February 2005 (Vol. 47, Issue 2, Pages 137-146)
    Abstract | Full Text | Full-Text PDF (232 KB)

  1. Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg , 08 June 2007
    Christopher R. Chapple, Aino Fianu-Jonsson, Mark Indig, Vik Khullar, José Rosa, Roberto M. Scarpa, Arun Mistry, D. Mark Wright, John Bolodeoku, for the STAR study group
    European Urology
    October 2007 (Vol. 52, Issue 4, Pages 1195-1203)
    Abstract | Full Text | Full-Text PDF (483 KB)

  1. A Multicenter, Randomized, Double-Blind, Crossover Study to Evaluate Patient Preference between Tadalafil and Sildenafil
    Alexander von Keitz, Jacob Rajfer, Scott Segal, Aileen Murphy, Jonathan Denne, Timothy Costigan, Daniel Lockhart, Charles M. Beasley, Jeffrey T. Emmick
    European Urology
    April 2004 (Vol. 45, Issue 4, Pages 499-509)
    Abstract | Full Text | Full-Text PDF (195 KB)

  1. Current and Future Strategies for Preventing and Managing Erectile Dysfunction Following Radical Prostatectomy
    Francesco Montorsi, Alberto Briganti, Andrea Salonia, Patrizio Rigatti, Arthur L Burnett
    European Urology
    February 2004 (Vol. 45, Issue 2, Pages 123-133)
    Abstract | Full Text | Full-Text PDF (163 KB)

  1. Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004) , 24 February 2006
    Christopher R. Chapple, Albena Patroneva, Shane R. Raines
    European Urology
    May 2006 (Vol. 49, Issue 5, Pages 879-886)
    Abstract | Full Text | Full-Text PDF (302 KB)

  1. Inhibition of bcl-2 Enhances the Efficacy of Chemotherapy in Renal Cell Carcinoma , 14 December 2004
    I. Kausch, H. Jiang, B. Thode, C. Doehn, S. Krüger, D. Jocham
    European Urology
    May 2005 (Vol. 47, Issue 5, Pages 703-709)
    Abstract | Full Text | Full-Text PDF (277 KB)

  1. Role of Bisphosphonates in Prostate Cancer
    Fred Saad, Claude C. Schulman
    European Urology
    January 2004 (Vol. 45, Issue 1, Pages 26-34)
    Abstract | Full Text | Full-Text PDF (256 KB)

  1. Psycho-Biological Correlates of Rapid Ejaculation in Patients Attending an Andrologic Unit for Sexual Dysfunctions , 19 August 2004
    G. Corona, L. Petrone, E. Mannucci, E.A. Jannini, R. Mansani, A. Magini, R. Giommi, G. Forti, M. Maggi
    European Urology
    November 2004 (Vol. 46, Issue 5, Pages 615-622)
    Abstract | Full Text | Full-Text PDF (204 KB)

  1. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia , 17 April 2008
    Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov
    European Urology
    July 2008 (Vol. 54, Issue 1, Pages 170-180)
    Abstract | Full Text | Full-Text PDF (561 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 24 results   Next 4>

Results Page:  [1]  2

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement